This process is modulated by proinflammatory mediators, such as TNFα, CCL3, and CCL2 (MCP-1), leading to hypoxia, ARDS, and possibly death for COVID-19 patients (2). The gene discussed is CCL3; the disease is acute respiratory distress syndrome.